Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
Lilly's revenue growth in Q1 2022 increased 15%, driven by volume growth of 20%. Excluding revenue from COVID-19 antibodies and Alimta, Q1 2022 revenue grew...
Source: prnewswire.com
